Search research articles
Contact Us
Filters
Showing results (51-60 of 182) with videos related to
Page
of 19
Sort By:
The Journal of Experimental Biology
|
June 19, 1998
Kinematic models of the buccal mass of Aplysia californica
R F Drushel, D M Neustadter, I Hurwitz, et al.
Preventive Medicine
|
January 1, 1982
Relationship of psychosocial factors to smoking behavior change in an intervention program
J K Ockene, R C Benfari, R L Nuttall, et al.
Journal of Applied Microbiology
|
August 26, 2009
Development of paratransgenic Artemia as a platform for control of infectious diseases in shrimp mariculture
B Subhadra, I Hurwitz, A Fieck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
Fairooz F Kabbinavar, Julie Hambleton, Robert D Mass, et al.
Journal of Neurophysiology
|
February 26, 1999
Actions of a pair of identified cerebral-buccal interneurons (CBI-8/9) in Aplysia that contain the peptide myomodulin
Y Xin, I Hurwitz, R Perrins, et al.
Investigational New Drugs
|
July 5, 2014
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
Yingmiao Liu, Hongyu Tian, Gerard C Blobe, et al.
Anti-Cancer Drugs
|
January 1, 2013
Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer
Jingquan Jia, Alex Starodub, Ian Cushman, et al.
Journal of Cancer Research and Clinical Oncology
|
November 12, 2009
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
James Cassidy, Leonard B Saltz, Bruce J Giantonio, et al.
Cancer Treatment Reviews
|
April 27, 2020
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia, Herbert I Hurwitz, Alan B Sandler, et al.
Cancer Chemotherapy and Pharmacology
|
July 5, 2006
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
Herbert I Hurwitz, Roger B Cohen, J Patrick McGovren, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 182) with videos related to
Sort By:
Page
of 19
The Journal of Experimental Biology
|
June 19, 1998
Kinematic models of the buccal mass of Aplysia californica
R F Drushel, D M Neustadter, I Hurwitz, et al.
Preventive Medicine
|
January 1, 1982
Relationship of psychosocial factors to smoking behavior change in an intervention program
J K Ockene, R C Benfari, R L Nuttall, et al.
Journal of Applied Microbiology
|
August 26, 2009
Development of paratransgenic Artemia as a platform for control of infectious diseases in shrimp mariculture
B Subhadra, I Hurwitz, A Fieck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
Fairooz F Kabbinavar, Julie Hambleton, Robert D Mass, et al.
Journal of Neurophysiology
|
February 26, 1999
Actions of a pair of identified cerebral-buccal interneurons (CBI-8/9) in Aplysia that contain the peptide myomodulin
Y Xin, I Hurwitz, R Perrins, et al.
Investigational New Drugs
|
July 5, 2014
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
Yingmiao Liu, Hongyu Tian, Gerard C Blobe, et al.
Anti-Cancer Drugs
|
January 1, 2013
Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer
Jingquan Jia, Alex Starodub, Ian Cushman, et al.
Journal of Cancer Research and Clinical Oncology
|
November 12, 2009
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
James Cassidy, Leonard B Saltz, Bruce J Giantonio, et al.
Cancer Treatment Reviews
|
April 27, 2020
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia, Herbert I Hurwitz, Alan B Sandler, et al.
Cancer Chemotherapy and Pharmacology
|
July 5, 2006
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
Herbert I Hurwitz, Roger B Cohen, J Patrick McGovren, et al.
Page
of 19